Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Mikkel W, Pedersen"'
Autor:
Zhengquan Gu, Yu Gao, Yiru Wang, Jishuai Yang, Jingkun Ran, Xiaoyan Yang, Wangdue Shargan, Mikkel W. Pedersen, Guilian Sheng, Yucheng Wang, Fahu Chen
Publikováno v:
Science China Earth Sciences. 66:840-851
Autor:
Laura Parducci, Inger Greve Alsos, Per Unneberg, Mikkel W. Pedersen, Lu Han, Youri Lammers, J. Sakari Salonen, Minna M. Väliranta, Tanja Slotte, Barbara Wohlfarth
Publikováno v:
Frontiers in Ecology and Evolution, Vol 7 (2019)
The lake sediments of Hässeldala Port in south-east Sweden provide an archive of local and regional environmental conditions ~14.5–9.5 ka BP (thousand years before present) and allow testing DNA sequencing techniques to reconstruct past vegetation
Externí odkaz:
https://doaj.org/article/5585f9615e8e4d61988946d1252c45c6
Autor:
Josep Tabernero, Anthony W. Tolcher, Eric Van Cutsem, Stephan Braun, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Rikke Hald, Ulla H. Hansen, Niels J.Ø. Skartved, Guillem Argilés, Rachel S. van der Post, Bastiaan B.J. Tops, Susana Roselló, Marta Benavent, Andrés Cervantes, Rocio Garcia-Carbonero, Amita Patnaik, Rodrigo Dienstmann
Figure legend to Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d189063a42e0a6e96b003b9ed5941a54
https://doi.org/10.1158/2159-8290.22530213.v1
https://doi.org/10.1158/2159-8290.22530213.v1
Autor:
Paul M. Harari, Mikkel W. Pedersen, Michael Kragh, Eric A. Armstrong, Chunrong Li, Jarob Saker, Chimera R. Peet, Shyhmin Huang
PDF - 189KB, Comparison between Sym004 and cetuximab on radiosensitivity response.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df80b3c9dd4f0c66f87fe381ba0b13c
https://doi.org/10.1158/1535-7163.22499005.v1
https://doi.org/10.1158/1535-7163.22499005.v1
Autor:
Mikkel W. Pedersen, Morag Park, Thomas Bouquin, Johan Lantto, Michael Kragh, Ivan D. Horak, Helle J. Jacobsen, George F.Vande Woude, Dafna Kaufman, Karsten W. Eriksen, Sara Collins, Paolo Conrotto, Gunther R. Galler, Anna Dahlman, Klaus Koefoed, Thomas T. Poulsen, Serhiy Havrylov, Michael M. Grandal
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1502dd7ee904c7154708f598a0ed2ed5
https://doi.org/10.1158/1535-7163.22505550.v1
https://doi.org/10.1158/1535-7163.22505550.v1
Autor:
Josep Tabernero, Anthony W. Tolcher, Eric Van Cutsem, Stephan Braun, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Rikke Hald, Ulla H. Hansen, Niels J.Ø. Skartved, Guillem Argilés, Rachel S. van der Post, Bastiaan B.J. Tops, Susana Roselló, Marta Benavent, Andrés Cervantes, Rocio Garcia-Carbonero, Amita Patnaik, Rodrigo Dienstmann
Supplementary Table S2. Sym004 pharmacokinetic derived measures - dose-escalation and dose-expansion cohorts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68eedc090ea26524fb654211680e7005
https://doi.org/10.1158/2159-8290.22530204.v1
https://doi.org/10.1158/2159-8290.22530204.v1
Autor:
Josep Tabernero, Anthony W. Tolcher, Eric Van Cutsem, Stephan Braun, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Rikke Hald, Ulla H. Hansen, Niels J.Ø. Skartved, Guillem Argilés, Rachel S. van der Post, Bastiaan B.J. Tops, Susana Roselló, Marta Benavent, Andrés Cervantes, Rocio Garcia-Carbonero, Amita Patnaik, Rodrigo Dienstmann
Supplementary Figure S1. Pharmacokinetic profile of Sym004.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c982b1b7cb7cb0729c25487d194dd2e
https://doi.org/10.1158/2159-8290.22530210.v1
https://doi.org/10.1158/2159-8290.22530210.v1
Autor:
Josep Tabernero, Anthony W. Tolcher, Eric Van Cutsem, Stephan Braun, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Rikke Hald, Ulla H. Hansen, Niels J.Ø. Skartved, Guillem Argilés, Rachel S. van der Post, Bastiaan B.J. Tops, Susana Roselló, Marta Benavent, Andrés Cervantes, Rocio Garcia-Carbonero, Amita Patnaik, Rodrigo Dienstmann
Tumor growth in the context of EGFR inhibitor resistance may remain EGFR-dependent and is mediated by mechanisms including compensatory ligand upregulation and de novo gene alterations. Sym004 is a two-antibody mixture targeting nonoverlapping EGFR e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::731402bd3be5a9cc862f4a0d2473b24f
https://doi.org/10.1158/2159-8290.c.6546126
https://doi.org/10.1158/2159-8290.c.6546126
Autor:
Paul M. Harari, Mikkel W. Pedersen, Michael Kragh, Eric A. Armstrong, Chunrong Li, Jarob Saker, Chimera R. Peet, Shyhmin Huang
PDF - 7KB, Quantification of EGFR mRNA expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f74b738b57ab0bff4dcd9cabf55b1e5
https://doi.org/10.1158/1535-7163.22498996
https://doi.org/10.1158/1535-7163.22498996
Autor:
Mikkel W. Pedersen, Morag Park, Thomas Bouquin, Johan Lantto, Michael Kragh, Ivan D. Horak, Helle J. Jacobsen, George F.Vande Woude, Dafna Kaufman, Karsten W. Eriksen, Sara Collins, Paolo Conrotto, Gunther R. Galler, Anna Dahlman, Klaus Koefoed, Thomas T. Poulsen, Serhiy Havrylov, Michael M. Grandal
Supplementary figure 1. Sym015 inhibits viability of cell lines in a synergic manner; Supplementary figure 2. The Sym015 antibodies Hu9338 and Hu9006 bind to 2nd or 3rd blades of MET and block HGF binding; Supplementary figure 3. Sym015 induces MET i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88967022fe0e668bd3a4d1f94d334d40
https://doi.org/10.1158/1535-7163.22505553
https://doi.org/10.1158/1535-7163.22505553